$4.93
0.153.14%
At close: Sep 16, 5:00 PM EST
$4.93
N/A
After Hours: 4:00 PM EST
TriSalus Life Sciences Inc
TLSINASDAQ
TriSalus Life Sciences Earnings & Forecasts
TriSalus Life Sciences (TLSI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TriSalus Life Sciences Guidance
TriSalus Life Sciences (TLSI) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided revenue in the range of $54M - $57M for the period.
Compared to prior guidance, TriSalus Life Sciences maintained its revenue forecast from a prior range of $54M - $57M.
TriSalus Life Sciences has issued 10 guidance updates between March 11, 2024 and August 6, 2026. During this period, the company raised its outlook 5 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.16 | $-0.13 | $-0.17 |
| Actual | $-0.16 | $0.03 | $-0.21 | $-0.96 |
| Surprise | -45.5% | +118.8% | -61.5% | -464.7% |
| Revenue | ||||
| Estimate | $10.3M | $10.5M | $13.0M | $11.6M |
| Actual | $11.4M | $8.9M | $13.2M | $11.6M |
| Surprise | +11.1% | -14.9% | +1.42% | -0.70% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.12 | $-0.06 | $-0.11 | $-0.10 |
| Revenue | ||||
| Consensus | $14.6M | $18.7M | — | — |
